CPT code 84112 represents a laboratory assay that tests cervicovaginal fluid for amniotic fluid proteins to help identify premature rupture of membranes (PROM) in pregnant patients. This diagnostic procedure informs time-sensitive obstetric decisions such as monitoring, infection prevention, and delivery planning, making it a clinically significant code in maternity care.

Key national payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and payer coverage patterns. The publication outlines reimbursement benchmarks, common billing considerations, and recent policy or coding guidance that affect claim adjudication for this test.

This summary equips billing managers, laboratory directors, and obstetric clinicians with practical insights into how CPT code 84112 is used in clinical workflows, where it is typically performed, and the policy factors that influence coverage and payment. Data not available in the input are noted where applicable, and the report focuses on nationally relevant information rather than state-specific rules.